The flavonoid-rich fraction of Coreopsis tinctoria promotes glucose tolerance regain through pancreatic function recovery in streptozotocin-induced glucose-intolerant rats

Journal of Ethnopharmacology

Volumn 132, Issue 2, 2010, Pages 483-490

  Dias, Teresa ^a   Bronze, Maria Rosário ^a,b   Houghton, Peter J ^c   Mota Filipe, Hélder ^a   Paulo, Alexandra ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antihyperglycaemia; Asteraceae; Coreopsis tinctoria; Diabetes; Flavonoids; Glucose tolerance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHALCONE DERIVATIVE; COREOPSIS TINCTORIA EXTRACT; FLAVANONE DERIVATIVE; FLAVONOID; GLUCOSE; INSULIN; MAREIN; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL LIPASE; TROLOX C; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; COREOPSIS TINCTORIA; DRUG INFUSION; DRUG MECHANISM; FLOWER; GLUCOSE ABSORPTION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; INSULIN RELEASE; MALE; MASS SPECTROMETRY; MEDICINAL PLANT; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PORTUGAL; QUANTITATIVE ANALYSIS; RAT; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CHALCONES; COREOPSIS; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; FLOWERS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; STREPTOZOCIN;

ANIMALIA; ASTERACEAE; COREOPSIS TINCTORIA; RATTUS; RATTUS NORVEGICUS;

EID: 78049362744     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.08.048     Document Type: Article

References (32)

1. Alberti K.G.M.M. The clinical implications of impaired glucose tolerance. Diabetic Medicine 1996, 13:927-937.
2. Arulmozhi D.K., Kurian R., Bodhankar S.L., Veeranjaneyulu A. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes. Journal of Pharmacy and Pharmacology 2008, 60:1167-1173.
3. Bagri P., Ali M., Aeri V., Bhowmik M., Sultana S. Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food and Chemical Toxicology 2009, 47:50-54.
4. Bandyopadhyay U., Das D., Banerjee R.K. Reactive oxygen species: oxidative damage and pathogenesis. Current Science 1999, 77:658-666.
5. Bojunga J., Nowak D., Mitrou P.S., Hoelzer D., Zeuzem S., Chow K.U. Antioxidative treatment prevents activation of death-receptor and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 2004, 47:2072-2080.
6. Brownlee M. A radical explanation for glucose-induced beta-cell disfunction. Journal of Clinical Investigation 2003, 112:1788-1790.
7. Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacological Research 2005, 51:117-123.
8. Cui Y., Ran X. Zhonghua yao hai - "The sea of Chinese Medicine" 1993, Harbin Publishing House, 1680 pp.
9. Dias T., Mota-Filipe H., Liu B., Jones, Houghton P.J., Paulo A. Recovery of oral glucose tolerance by Wistar rats after treatment with Coreopsis tinctoria infusion. Phytotherapy Research 2010, 24:699-705.
10. D'Oliveira Feijão R. Medicina pelas plantas 1973, Livraria Progresso Editora, Lisboa, pp. 19, 156. sixth ed.
11. Fabre N., Rustan I., Hoffmann E., Quintin-Leclerck J. Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry. Journal of the American Society for Mass Spectrometry 2001, 12:707-715.
12. Foster S., Duke J.A. A Field Guide to Medicinal Plants. Eastern and Central North America 1990, Houghton Mifflin Co.
13. Frode T.S., Medeiros Y.S. Animal models to test drugs with potential antidiabetic activity. Journal of Ethnopharmacology 2008, 115:173-183.
14. Harborne J.B. Variations in pigment patterns in Pyrrhopappus and related taxa of the Cichorieae. Phytochemistry 1977, 16:927-928.
15. Hotta M., Yamato E., Miyazaki J. Oxidative stress and pancreatic beta-cell destruction in insulin dependent diabetes mellitus. Antioxidants in Diabetes Management 2000, 265-274. Marcel Dekker, Inc., New York. L. Packer, P. Rosen, H.J. Tritschler, H.J. King, A. Azzi (Eds.).
16. Huá Shòu, Yuan Dinasty 1271-1368 DC. Mazhen quanshu. "Complete treatise on Measles".
17. Jia Q., Liu X., Wu X., Wang R., Hu X., Li Y., Huang C. Hypoglycemic activity of a polyphenolic oligomer-rich extract of Cinnamomum parthenoxylon bark in normal and streptozotocin-induced diabetic rats. Phytomedicine 2009, 16:744-750.
18. Kim E.K., Kwon K.B., Song M.Y., Han M.J., Lee J.H., Lee Y.R., Lee J.H., Ryu D.G., Park B.H., Park J.W. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappa-B activation. Pancreas 2007, 35:1-9.
19. Kim J.O., Kim K.S., Lee G.D., Kwon J.H. Antihyperglycemic and antioxidative effects of new herbal formula in streptozotocin-induced diabetic rats. Journal of Medicinal Food 2009, 12:728-735.
20. Lee Y.J., Suh K.S., Choi M.C., Chon S.O.S., Woo J., Kim S., Kim J.W., Kim Y.S. Kaempferol protects HIT-T15 pancreatic beta cells from 2-deoxy-d-ribose-induced oxidative damage. Phytotherapy Research 2010, 24:419-423.
21. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008, 51:216-226.
22. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003, 17:24-38.
23. Markham K.R., Mabry T.J. Ultraviolet-visible and proton magnetic resonance spectroscopy of flavonoids. The Flavonoids 1975, 45-77. Chapman & Hall, London. J.B. Harborne, T.J. Mabry, H. Mabry (Eds.).
24. Nathan D.M., Mayer Davidson, De Fronzo R.A., Heine R.J., Henry R.R., Pratley R., Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007, 30:753-759.
25. Pinent M., Castell A., Baiges I., Montagut G., Arola L., Ardévol A. Bioactivity of flavonoids on insulin-secreting cells. Comprehensive Review in Food Science and Food Safety 2008, 7:299-308.
26. Prince P.S.M., Kamalakkannan N. Rutin improves homeostasis in streptozotocin diabetic tissues by altering glycolitic and gluconeogenic enzymes. Journal Biochemistry and Molecular Toxicology 2006, 20:96-102.
27. Steppel J.H., Horton E.S. Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Current Diabetes Reports 2004, 4:169-175.
28. Thomas D.A., Stauffer C., Zhao K., Yang H., Sharma V.K., Szeto H.H., Suthanthiran M. Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function. Journal of the American Society of Nephrology 2007, 18:213-222.
29. Unwin N., Shaw J., Zimmet P., Alberti K.G.M.M. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Medicine 2002, 19:708-723.
30. WHO/DIF, World Health Organization/International Diabetes Federation Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation 2006, World Health Organization, Geneva, Switzerland.
31. Zhang Y., Shi S., Zhao M., Jiang Y., Tu P. A novel chalcone from Coreopsis tinctoria. Biochemical Systematics and Ecology 2006, 34:766-769.
32. Zhang Y., Zhang P., Cheng Y. Structural characterization of isoprenylated flavonoids from Kushen by electrospray ionization multistage tandem mass spectrometry. Journal of Mass Spectrometry 2008, 43:1421-1431.